Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$41.7M
2 rounds on record
Latest round
$28.4M
Venture round · Jun 2018 · 8 yr ago
Team
58
US Form 5500 (plan participants) · Dec 2024
Backers
2
Cota Capital, Fusion Fund
The money's age
Long since its last round
98 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jun 2018 $28.4M — SEC Form D
Venture round Jun 2017 $13.3M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Mission Bio, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Charles SilverExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
1Cell.Ai11-50 employees
Learn how 1Cell.ai uses AI powered single cell multi omic analysis to advance biomarker discovery, therapy monitoring, and patient…
Panome BioVenture round $6M · 22 mo ago • Founded 2022 • 11-50 employees
Panome Bio delivers advanced multi-omics services including Next-Generation Metabolomics, Discovery Proteomics, Transcriptomics, and…
MissPompadourFounded 2019 • 11-50 employees
Read all about MissPompadour and the team. About MissPompadour – find out who’s behind the company.
Sapient2 roles
Discover dynamic biomarkers beyond the genome. Our multi-omics services enable profiling of thousands of metabolites, lipids & proteins per…
OverT BioVenture round $16M · 3 yr ago • Founded 2022 • 51-200 employees
OverT is redefining what's possible with programmed, off-the-shelf cell therapies and biologics.
Take control of your works' AIRights and get compensated for their use by AIcompanies.

Overview

We offer the only multi-omics single-cell technology solution that simultaneously detects SNV, CNV, and protein data from the same cell. Find out more.

People

Charles Silver
Executive Officer, Director
Paul Billings M.D. Ph.D.
Director
Urshit Parikh
Director
Maneesh Jain Ph.D.
Director
Adam Abate Ph.D.
Director
Brock Siegel Ph.D.
Director
Allison Ballmer
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
South San Francisco United States
HQ
San Francisco United States
HQ
Clinical Utility of Single-Cell CXCR4 Biomarker Stratification for Motixafortide Treated Acute Myeloid Leukemia Patients
300 Utah Avenue, Suite 210South San Francisco, CA, 94080
company site

Financials

Total raised
$41.7M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2018 $28.4M Details
Venture - Series Unknown 2017 $13.3M Details